脂肪肝中西醫療法

Combination Treatment of Chinese Medicine and Western Medicine on Fatty Liver

10.7102/JTCIM.201306_11(1).0004

鄭振鴻(Chen-Hung Cheng)

非酒精性脂肪性肝病 ； 慢性肝病 ； Non-alcoholic fatty liver disease (NAFLD) ； chronic liver disease

中醫內科醫學雜誌

11卷1期（2013 / 06 / 01）

36 - 41

繁體中文

非酒精性脂肪性肝病（NAFLD），隨著肥胖和代謝綜合症的逐漸增多，近20年來NAFLD增長迅速且低齡化趨勢，已成為全球重要公共健康問題之，台灣愈來愈重要常見慢性肝病。西醫多年探討研究提出二次打擊四階段的病理機轉，但治療尚有缺失，中醫依照辨證論治分有（1）肝鬱氣滯證（2）肝鬱脾虛證（3）痰濕內阻證（4）濕熱蘊結證（5）痰瘀互結證，之中醫療法，在中西醫結合治療下，促使治療率提高，以供中西醫界參考。

Non-alcoholic fatty liver disease (NAFLD), an important chronic liver disease in Taiwan, increases with obesity and metabolic syndrome and has become the most important global public health problem in recent 20 years. Two-hit hypothesis in 4 phases is studied and the treatment is not well-arranged. We gave combination treatment of Chinese medicine and Western medicine under the 5 identified patterns: (1) pattern of liver depression and qi stagnation, (2) pattern of liver depression and spleen deficiency, (3) pattern of internal obstruction of phlegm-dampness, (4) pattern of retained dampness-heat, (5) pattern of phlegm combined with static blood

1. Caldwell, SH,Oelsner, DH,Lezzni, JC,Hespenheide, EE,Battle, EH,Driscoll, CJ(1999).Crytogenic cirrhosis: Clinical characterization and risk factors for underlying disease.Hepatology,29,664-669.
2. Cao, HX,Fan, JG(2011).Fatty liver disease.J Dig Dis,12(1),1-2.
3. EcKel, RH,Grundy, SM,Zimmet, PZ(2005).The metabolic syndrome.LANCET,365(9468),1415-1428.
4. Nugent, C,Younossi, ZM(2007).Evaluation and management of obesity-relate nonalcoholic fatty liver disease.Gastroenterology Hepatol,4(8),432-441.
5. 周福生編(2010)。肝病中醫臨證旨要。廣東科技出版社。
6. 陳灝珠編、林果為編(2009)。實用內科學。人民衛生出版社。
7. 遲家敏編(2010)。實用血脂學。人民衛生出版社。
8. 魏瑋編、唐艷萍編(2012)。消化系統西醫難治病種 中西醫結合診療方略。人民衛生出版社。